Clinical trial

Test Albuvirtide in Experienced Patients

NCT02369965

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-19

PhasePHASE3

Study timeline

Study start (actual)2014-02-19Date precision: day

Registry last updated2021-10-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

AIDSunresolved

Interventions

albuvirtideDRUG

lopinavir-ritonavirDRUG

tenofovirDRUG

lamivudineDRUG

Sponsors & collaborators

Frontier Biotechnologies Inc.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China3 HangzhouZhejiang, China2 ChangshaHunan, China2 ShanghaiShanghai Municipality, China1 GuangzhouGuangdong, China1 ZhengzhouHenan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02369965 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.